SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: tom r. phillips who wrote (85642)11/17/2000 1:54:16 PM
From: Knighty Tin  Read Replies (3) | Respond to of 132070
 
Tom, Estimates are never real, but they don't look too fantastic to me. This is a co. with huge growth in front of it, IMHO, and a stock price that doesn't begin to reflect it. My guess is that when eps get to be more than the price of the stock, it will go up. Of course, a small co. in an odd area like Vaso's could fold up its tent and blow away, too, but I think the odds of that are fairly low.



To: tom r. phillips who wrote (85642)11/17/2000 10:29:59 PM
From: PaperChase  Read Replies (1) | Respond to of 132070
 
I glanced at VASO and I noticed that their R&D expense is rather anemic. This could be a result of not having ongoing clinical trials, etc. I think that their profit is an illusion of sorts since their R&D expense is below the industry norm.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News